tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market

BridgeBio Pharma (BBIO) Income Statement

Compare
1,432 Followers

BridgeBio Pharma Income Statement

Last quarter (Q3 2025), BridgeBio Pharma's total revenue was $120.70M, an increase of 4318.01% from the same quarter last year. In Q3, BridgeBio Pharma's net income was $-182.74M. See BridgeBio Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 221.90M$ 9.30M$ 77.65M$ 69.72M$ 8.25M
Gross Profit
$ 218.02M$ 6.86M$ 74.21M$ 66.60M$ 8.25M
Operating Expenses
$ 811.00M$ 614.23M$ 586.42M$ 643.23M$ 482.73M
Depreciation and Amortization
$ 6.08M$ 6.49M$ 6.77M$ 5.84M$ 1.46M
EBITDA
$ -436.83M$ -565.47M$ -397.44M$ -533.83M$ -467.38M
Operating Income
$ -592.97M$ -607.37M$ -512.20M$ -576.63M$ -474.48M
Other Income/Expenses
$ 50.78M$ -45.88M$ 27.55M$ -9.82M$ -31.01M
Pretax Income
$ -542.19M$ -653.25M$ -484.65M$ -586.45M$ -505.49M
Net Income
$ -535.76M$ -643.20M$ -481.18M$ -562.54M$ -448.72M
Per Share Metrics
Basic EPS
$ -2.88$ -3.95$ -3.35$ -4.43$ -4.10
Diluted EPS
$ -2.88$ -3.95$ -3.35$ -4.43$ -4.10
Weighted Average Shares Outstanding
186.08M 162.79M 147.47M 144.36M 118.00M
Weighted Average Shares Outstanding (Diluted)
186.08M 162.79M 147.47M 144.36M 118.00M
Currency in USD

BridgeBio Pharma Earnings and Revenue History